Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Change in Account Payables (2016 - 2025)

Marimed (MRMD) has disclosed Change in Account Payables for 15 consecutive years, with $3.5 million as the latest value for Q4 2025.

  • Quarterly Change in Account Payables rose 11134.38% to $3.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $841000.0 through Dec 2025, down 79.92% year-over-year, with the annual reading at $841000.0 for FY2025, 79.92% down from the prior year.
  • Change in Account Payables for Q4 2025 was $3.5 million at Marimed, up from $23000.0 in the prior quarter.
  • The five-year high for Change in Account Payables was $3.5 million in Q4 2025, with the low at -$2.8 million in Q2 2025.
  • Average Change in Account Payables over 5 years is $426800.0, with a median of $453000.0 recorded in 2021.
  • The sharpest move saw Change in Account Payables tumbled 278.92% in 2022, then soared 11134.38% in 2025.
  • Over 5 years, Change in Account Payables stood at -$2.0 million in 2021, then skyrocketed by 32.51% to -$1.3 million in 2022, then skyrocketed by 137.7% to $507000.0 in 2023, then plummeted by 106.31% to -$32000.0 in 2024, then skyrocketed by 11134.38% to $3.5 million in 2025.
  • According to Business Quant data, Change in Account Payables over the past three periods came in at $3.5 million, $23000.0, and -$2.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.